Shingrix vaccine shows promise beyond preventing shingles. A study indicates it may reduce stroke and heart attack risks. It also protects ...

So, now 31% margin for Divi’s is a good thing as against the lower margin what it used to clock. And going forward, this kind of margins ar...

GlaxoSmithKline Pharmaceuticals (GSK India) on Wednesday reported 13% year-on-year (YoY) jump of net profit to Rs 131 crore for the quarter...

GSK India reported a net profit of Rs 133 crore for the quarter ended March 31, 2023, with continued momentum across general medicines and ...

The adult vaccine recommended for people aged 50 years and above, provides protection against shingles - a disease associated with debilita...

GlaxoSmithKline Pharmaceuticals, incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 21358.71 Crore) operating...

First reported by CCTV state television, the ban was imposed by authorities after a batch of GSK's prostate treatment - known chemically as...

Indian pharmaceutical companies are becoming more aggressive and increasing their market share and capex. Companies such as Divis, Dr Reddy...

About 12.8 million people — or about 8% of the fully vaccinated population in the United States — have received the Johnson & Johnson shot.